Immunome (IMNM) News Today → Claim Your Complimentary Bitcoin Reward (From Crypto Swap Profits) (Ad) Free IMNM Stock Alerts $24.68 -0.84 (-3.29%) (As of 03/28/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineLeerink Partnrs Weighs in on Immunome, Inc.'s Q1 2024 Earnings (NASDAQ:IMNM)marketbeat.com - March 29 at 8:16 AMIMNM Stock Earnings: Immunome Beats EPS, Beats Revenue for Q4 2023investorplace.com - March 29 at 2:01 AMTD Cowen Reaffirms Their Buy Rating on Immunome (IMNM)markets.businessinsider.com - March 28 at 11:33 PMImmunome (NASDAQ:IMNM) Shares Down 3.7% marketbeat.com - March 28 at 4:33 PMImmunome Reports Full Year 2023 Financial Results and Provides Update on Recently Acquired Assetsbusinesswire.com - March 28 at 4:06 PMImmunome Reports Full Year 2023 Financial Results and Provides Update on Recently Acquired Assetsbusinesswire.com - March 28 at 4:02 PMImmunome Completes Acquisition of AL102, a Phase 3 Asset for the Treatment of Desmoid Tumors, From Ayalafinance.yahoo.com - March 27 at 1:08 AMImmunome (NASDAQ:IMNM) Shares Up 5.3%marketbeat.com - March 26 at 4:46 PMImmunome (NASDAQ:IMNM) Shares Gap Up to $24.14americanbankingnews.com - March 24 at 2:24 AMImmunome, Inc. (NASDAQ:IMNM) surges 7.6%; individual investors who own 42% shares profited along with institutionsfinance.yahoo.com - March 22 at 10:45 AMImmunome (NASDAQ:IMNM) Trading Down 5%marketbeat.com - March 20 at 12:46 PMImmunome (NASDAQ:IMNM) Trading 7.3% Higher marketbeat.com - March 19 at 4:48 PMArrayjet’s ArrayPlex platform selected by Immunome for use in its discovery of targeted cancer therapiesmsn.com - March 18 at 10:37 AMArrayjet's ArrayPlex Platform Selected by Immunome for Use in Its Discovery of Targeted Cancer Therapiesbusinesswire.com - March 18 at 5:44 AMImmunome (NASDAQ:IMNM) Shares Down 6.3% marketbeat.com - March 11 at 3:17 PMImmunome (NASDAQ:IMNM) Sets New 1-Year High at $29.40marketbeat.com - March 7 at 10:51 AMImmunome to Participate in the Leerink Partners Global Biopharma Conferencebusinesswire.com - March 7 at 8:00 AM49,712 Shares in Immunome, Inc. (NASDAQ:IMNM) Purchased by Acadian Asset Management LLCmarketbeat.com - March 2 at 5:28 AMImmunome to Participate in the TD Cowen 44th Annual Healthcare Conferencebusinesswire.com - March 1 at 8:00 AMBiotech Stocks Surge To Start 2024: 'Charts Look Great,' But Will The Trend Continue?msn.com - February 28 at 2:47 PMImmunome (NASDAQ:IMNM) Hits New 1-Year High at $27.56marketbeat.com - February 28 at 11:29 AMImmunome (IMNM) Price Target Increased by 179.17% to 34.17msn.com - February 24 at 8:51 AMImmunome Stock (NASDAQ:IMNM), Short Interest Reportbenzinga.com - February 22 at 10:13 AMImmunome Recognizes Ayala Pharmaceuticals’ Announced Completion of Enrollment in Phase 3 RINGSIDE Study Evaluating AL102 in Desmoid Tumorsfinance.yahoo.com - February 20 at 10:40 AMImmunome Recognizes Ayala Pharmaceuticals' Announced Completion of Enrollment in Phase 3 RINGSIDE Study Evaluating AL102 in Desmoid Tumorsbusinesswire.com - February 20 at 8:15 AMIMNM Apr 2024 30.000 callfinance.yahoo.com - February 19 at 12:54 AMIMNM Mar 2024 10.000 putfinance.yahoo.com - February 19 at 12:54 AMIMNM Jul 2024 25.000 putca.finance.yahoo.com - February 17 at 11:26 PMIMNM Mar 2024 20.000 putca.finance.yahoo.com - February 17 at 11:26 PMIMNM Apr 2024 12.500 putfinance.yahoo.com - February 17 at 6:26 PMIMNM Apr 2024 7.500 callfinance.yahoo.com - February 17 at 1:26 PMIMNM Mar 2024 22.500 putfinance.yahoo.com - February 17 at 1:26 PMImmunome Announces Closing of Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Sharesfinance.yahoo.com - February 16 at 5:09 PMImmunome Announces Closing of Public Offering and Full Exercise of Underwriters' Option to Purchase Additional Sharesbusinesswire.com - February 16 at 4:05 PMImmunome (NASDAQ:IMNM) Reaches New 1-Year High at $26.78marketbeat.com - February 16 at 2:56 PMImmunome (NASDAQ:IMNM) Shares Gap Down to $22.39marketbeat.com - February 14 at 12:01 PMImmunome down 1%, prices $200M equitymsn.com - February 14 at 3:30 AMImmunome Prices Public Offering Of 10 Mln Shares At $20/Shrmarkets.businessinsider.com - February 14 at 3:30 AMImmunome Announces Pricing of Public Offering of Common Stockbusinesswire.com - February 13 at 10:38 PMImmunome Announces Proposed Public Offering of Common Stockfinance.yahoo.com - February 13 at 5:29 PMImmunome (NASDAQ:IMNM) Shares Up 2.7%marketbeat.com - February 13 at 12:55 PMInsiders See US$1.25m Investment In Immunome Jump Last Weekfinance.yahoo.com - February 10 at 8:30 AMQ1 2024 EPS Estimates for Immunome, Inc. Reduced by Leerink Partnrs (NASDAQ:IMNM)marketbeat.com - February 9 at 6:43 AMImmunome Issues Private Equity Shares to Ayalamsn.com - February 7 at 9:48 AMImmunome Strikes Deal to Acquire Ayala’s Drug Programsmsn.com - February 7 at 9:48 AMImmunome (NASDAQ:IMNM) Reaches New 52-Week High at $19.66marketbeat.com - February 6 at 2:00 PMImmunome To Acquire AL102, AL101 Drug Candidates From Ayala Pharmamarkets.businessinsider.com - February 6 at 10:19 AMImmunome (NASDAQ:IMNM) Stock Price Up 2.6%marketbeat.com - February 5 at 2:37 PM4D Molecular stock jumps after positive interim data for eye disease drugseekingalpha.com - February 5 at 8:41 AMImmunome to Present at the Guggenheim Healthcare Talks 6th Annual Biotechnology Conferencefinance.yahoo.com - February 5 at 8:41 AM Get Immunome News Delivered to You Automatically Sign up to receive the latest news and ratings for IMNM and its competitors with MarketBeat's FREE daily newsletter. Email Address Central Banks Preparing for US Dollar Collapse? (Ad)China is spearheading this blatant de-dollarization push, dominating the physical gold market through massive central bank buying. Their ultimate goal? Ditching the greenback in favor of local BRICS currencies. Find out how you can protect yourself now >>> IMNM Media Mentions By Week IMNM Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. IMNM News Sentiment▼0.680.61▲Average Medical News Sentiment IMNM News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. IMNM Articles This Week▼122▲IMNM Articles Average Week Get Immunome News Delivered to You Automatically Sign up to receive the latest news and ratings for IMNM and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: BLTE News Today ABCL News Today PRTA News Today VIR News Today LGND News Today PCRX News Today MNKD News Today MIRM News Today IRWD News Today KNSA News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:IMNM) was last updated on 3/29/2024 by MarketBeat.com Staff From Our PartnersTrump’s “Tax Free” Retirement Strategy Gold Safe ExchangeDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsMake This $3 Trade the Instant the Opening Bell RingsMonument Traders AllianceTop Project Outperforms BTC in 2023…Crypto 101 MediaOnly a fool would buy Nvidia today… Porter & CompanyForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm PressThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading Academy“The Stock Market’s Bull Run is Far from Over” -BarronsVertical Research Advisory Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Immunome, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.